Accelerated immune aging may contribute to obesity-linked metabolic disease

November 7, 2016, JCI Journals

Obese individuals are at an elevated risk of developing comorbid cardiovascular and metabolic diseases, such as type 2 diabetes. Some research suggests that these comorbid diseases develop in response to chronic inflammation that occurs in visceral adipose tissue, the fat deposits that accumulate around organs. Although obesity is linked to changes in immune cells, it is not clear how these changes influence pathological inflammation in specific fatty tissues.

Motoaki Sano and colleagues at the Keio University School of Medicine examined how changes in immune cell populations contribute to chronic visceral fat inflammation in a new study published this week in the JCI.

They found that large amounts of a T cell subtype with the characteristics of aging cells accumulate in the visceral fat of .

Transplanting this aged T cell population from obese mice into normal mice caused the normal mice to develop obesity-like inflammation in their visceral fat stores.

The also developed insulin resistance similar to that observed in obese mice.

Identifying this immune cell population as a driving force in obesity-linked inflammation points to a potential therapeutic target for preventing comorbid metabolic and cardiovascular disorders in .

Explore further: Study results suggest cell-free DNA may be involved in inflammation in obese patients

More information: Kohsuke Shirakawa et al, Obesity accelerates T cell senescence in murine visceral adipose tissue, Journal of Clinical Investigation (2016). DOI: 10.1172/JCI88606

Related Stories

Study results suggest cell-free DNA may be involved in inflammation in obese patients

March 28, 2016
(Medical Xpress)—A team of researchers affiliated with multiple facilities in Japan has found that as fat cells die due to an increase in obesity, more cell-free DNA is released into tissue causing inflammation. In their ...

Gamma-Delta T cells may play a role in insulin resistance and type 2 diabetes

January 5, 2015
New research in mice suggests that an unusual type of immune cell called "γδ T cells" may be a new drug and research target for treating or preventing type 2 diabetes caused by obesity. The research report, appearing in ...

Epigenomic alterations contribute to obesity-associated diabetes

June 6, 2016
Obesity is a risk factor for developing type 2 diabetes, yet not all obese humans develop the disease. In a new study, researchers from the Karolinska Institutet in Sweden and from the Institute of Health and Medical Research ...

Why is visceral fat worse than subcutaneous fat?

April 25, 2016
Researchers have long-known that visceral fat - the kind that wraps around the internal organs - is more dangerous than subcutaneous fat that lies just under the skin around the belly, thighs and rear. But how visceral fat ...

A boost in microRNA may protect against obesity and diabetes

March 15, 2016
Obesity, which is associated with low-grade inflammation, is an important contributor in the development of diabetes and cardiovascular disease. While the role of several organs including adipose tissue have been implicated ...

SHIP1 inhibitor reduces obesity and metabolic dysfunction in mice

July 21, 2016
Obesity can cause a variety of health complications in affected individuals. Several lines of evidence support an association between chronic inflammation in adipose tissue and obesity complications. In mice, inhibition of ...

Recommended for you

RNAi therapy mitigates preeclampsia symptoms

November 19, 2018
A collaboration of scientists from the University of Massachusetts Medical School, Beth Israel Deaconess Medical Center and Western Sydney University, have shown that an innovative new type of therapy using small interfering ...

Skeletal imitation reveals how bones grow atom-by-atom

November 19, 2018
Researchers from Chalmers University of Technology, Sweden, have discovered how our bones grow at an atomic level, showing how an unstructured mass orders itself into a perfectly arranged bone structure. The discovery offers ...

Signal peptides' novel role in glutamate receptor trafficking and neural synaptic activity

November 19, 2018
Glutamate is the major excitatory neurotransmitter in the brain, and the postsynaptic expression level of glutamate receptors is a critical factor in determining the efficiency of information transmission and the activity ...

New insights into how an ordinary stem cell becomes a powerful immune agent

November 19, 2018
How do individual developing cells choose and commit to their "identity"—to become, for example, an immune cell, or a muscle cell, or a neuron?

A molecule for fighting muscular paralysis

November 19, 2018
Myotubular myopathy is a severe genetic disease that leads to muscle paralysis from birth and results in death before two years of age. Although no treatment currently exists, researchers from the University of Geneva (UNIGE), ...

Mouse model aids study of immunomodulation

November 19, 2018
Because mice do not respond to immunomodulatory drugs (IMiDs), preclinical therapeutic and safety studies of the effects of IMiDs have not been possible in existing types of mice. This has led to an inability to accurately ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.